Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06076967 · ClinicalTrials.gov registry record · NA

Mindfulness Intervention for College Students With ADHD

A NA study of Attention Deficit Hyperactivity Disorder, sponsored by University of Alabama, Tuscaloo.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
2
Study locations

NCT06076967: Recruiting NA study of Attention Deficit Hyperactivity Disorder, sponsored by University of Alabama, Tuscaloo.

NCT06076967 is a NA study of Attention Deficit Hyperactivity Disorder that is actively recruiting participants, run by University of Alabama, Tuscaloo. The registered enrollment target is 100 participants, below the 216-participant average among 102 other Attention Deficit Hyperactivity Disorder trials with a reported enrollment target (54% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06076967, a NA study of Attention Deficit Hyperactivity Disorder, is actively recruiting participants, sponsored by University of Alabama, Tuscaloo.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
2
Study locations

Study Summary

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder that commonly persists into adulthood and is associated with significant life impairments. The current study evaluates the feasibility, acceptability, and preliminary efficacy of a group-based mindfulness intervention for first-year college students with ADHD. If found to be feasible, acceptable, and efficacious, subsequent research will examine its impact on a larger scale to have a broader public health impact for college students with ADHD.

Conditions Studied

Attention Deficit Hyperactivity Disorder

Interventions

  • BEHAVIORAL Mindfulness Awareness Practices for ADHD (adapted)
  • BEHAVIORAL Services-As-Usual

Study Locations (2)

Alabama

  • Department of Psychology, University of Alabama - Tuscaloosa

South Carolina

  • Department of Psychology, Wofford College - Spartanburg

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2023-09-15
Est. Completion 2026-07-31
Phase NA
University of Alabama, Tuscaloo

17 total trials

What NCT06076967 shows while recruiting

NCT06076967 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 216-participant average among 102 other Attention Deficit Hyperactivity Disorder trials with a reported enrollment target (54% lower).

The record links to 1 condition, with Attention Deficit Hyperactivity Disorder appearing as the primary indexed condition, and to 2 interventions - of which Mindfulness Awareness Practices for ADHD (adapted) is the first listed.

NCT06076967 reports a single indexed study location in Alabama, South Carolina.

Frequently Asked Questions

What is clinical trial NCT06076967 about?

NCT06076967 is a clinical study titled "Mindfulness Intervention for College Students With ADHD". Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder that commonly persists into adulthood and is associated with significant life impairments. The current study evaluates the feasibility, acceptability, and preliminary efficacy of a group-based mindfulness intervention f...

What is the current status of trial NCT06076967?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2023-09-15. Estimated completion is 2026-07-31.

What conditions does trial NCT06076967 study?

This clinical trial studies the following conditions: Attention Deficit Hyperactivity Disorder.

What interventions are being tested in trial NCT06076967?

The interventions under investigation include: Mindfulness Awareness Practices for ADHD (adapted) (BEHAVIORAL), Services-As-Usual (BEHAVIORAL).

Who is sponsoring clinical trial NCT06076967?

This trial is sponsored by University of Alabama, Tuscaloo, which has 17 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06076967 being conducted?

This trial has 2 study locations across Alabama, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Attention Deficit Hyperactivity Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06076967's enrollment target sits among peer trials

100 47th of 102 higher than 56 of 102 other Attention Deficit Hyperactivity Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Attention Deficit Hyperactivity Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT06076967

Source: ClinicalTrials.gov NCT06076967, the US trial registry maintained by the National Library of Medicine. NCT06076967 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.